Department of Molecular Regulation, Graduate School of Dentistry, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Eur J Pharmacol. 2013 Jan 15;699(1-3):14-22. doi: 10.1016/j.ejphar.2012.11.031. Epub 2012 Nov 28.
Nitrogen-containing bisphosphonates (NBPs) have greater anti-bone-resorptive effects than non-nitrogen-containing bisphosphonates (non-NBPs). Hence, NBPs are the current first-choice drug for osteoporosis. However, NBPs carry a risk of osteonecrosis of jaws. Some animal and human studies suggest that non-NBPs may have anti-bone-resorptive effect-independent analgesic effects, but there has been no detailed comparison between NBPs and non-NBPs. Here, we compared the analgesic effects of several non-NBPs and NBPs, using (a) writhing responses induced in mice by intraperitoneal injection of 1% acetic acid, (b) acetic acid-induced neuronal expression of c-Fos, (c) acetic acid-induced elevation of blood corticosterone, and (d) hindpaw-licking/biting responses induced by intraplantar injection of capsaicin. Among the NBPs and non-NBPs tested, only etidronate and clodronate displayed clear analgesic effects, with various routes of administration (including the oral one) being effective. However, they were ineffective when intraperitoneally injected simultaneously with acetic acid. Intracerebroventricular administration of etidronate or clodronate, but not of minodronate (an NBP), was also effective. The effective doses of etidronate and clodronate were much lower in writhing-high-responder strains of mice. Etidronate and clodronate reduced acetic acid-induced c-Fos expression in the brain and spinal cord, and also the acetic acid-induced corticosterone increase in the blood. Etidronate and clodronate each displayed an analgesic effect in the capsaicin test. Etidronate and clodronate displayed their analgesic effects at doses lower than those inducing anti-bone-resorptive effects. These results suggest that etidronate and clodronate exert potent, anti-bone-resorptive effect-independent analgesic effects, possibly via an interaction with neurons, and that they warrant reappraisal as safe drugs for osteoporosis.
含氮双膦酸盐(NBPs)比不含氮双膦酸盐(non-NBPs)具有更强的抗骨吸收作用。因此,NBPs 是目前治疗骨质疏松症的首选药物。然而,NBPs 存在颌骨坏死的风险。一些动物和人体研究表明,non-NBPs 可能具有抗骨吸收作用以外的镇痛作用,但尚未对 NBPs 和 non-NBPs 进行详细比较。在这里,我们比较了几种 non-NBPs 和 NBPs 的镇痛作用,使用了(a)腹腔注射 1%醋酸诱导的小鼠扭体反应,(b)醋酸诱导的神经元 c-Fos 表达,(c)醋酸诱导的血皮质酮升高,和(d)足底注射辣椒素诱导的舔/咬反应。在测试的 NBPs 和 non-NBPs 中,只有依替膦酸和氯膦酸表现出明显的镇痛作用,各种给药途径(包括口服)都有效。然而,当与醋酸同时腹腔内注射时,它们无效。依替膦酸或氯膦酸的脑室内给药,但不是米诺膦酸(一种 NBP)的脑室内给药,也是有效的。依替膦酸和氯膦酸在扭体反应高应答品系小鼠中的有效剂量要低得多。依替膦酸和氯膦酸降低了大脑和脊髓中醋酸诱导的 c-Fos 表达,也降低了血液中醋酸诱导的皮质酮增加。依替膦酸和氯膦酸在辣椒素测试中都表现出镇痛作用。依替膦酸和氯膦酸在发挥抗骨吸收作用的剂量以下表现出镇痛作用。这些结果表明,依替膦酸和氯膦酸发挥强大的、抗骨吸收作用以外的镇痛作用,可能通过与神经元相互作用,它们作为治疗骨质疏松症的安全药物值得重新评估。